Literature DB >> 11220987

Growth factors in clinical practice.

G B Köveker1.   

Abstract

Wound repair consists of a complex interaction of cellular and biochemical events. Several growth factors have been identified as regulatory polypeptides co-ordinating the healing process. Although it is not known precisely why chronic wounds do not follow the normal pattern of healing, diminished growth factor content and accelerated growth factor degradation may contribute to poor healing. Topical application of different factors exert stimulatory effects on wounds in animal models. Human data are limited but the most investigated compound is recombinant human platelet-derived growth factor-BB (rhPDGF-BB). PDGF-BB enhances granulation tissue formation and facilitates epithelialisation. Clinical trials in patients with 'hard to heal' diabetic foot ulcers demonstrated significant improvement in the 'healing rate' and the 'time to healing' compared with controls. Refinement of therapeutic strategies with growth factors will take place in the future.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11220987

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  9 in total

1.  Adenosine A2A receptor agonists promote more rapid wound healing than recombinant human platelet-derived growth factor (Becaplermin gel).

Authors:  Cassandre Victor-Vega; Avani Desai; M Carmen Montesinos; Bruce N Cronstein
Journal:  Inflammation       Date:  2002-02       Impact factor: 4.092

Review 2.  [Perioperative hypothermia. Impact on wound healing].

Authors:  A P Pietsch; N Lindenblatt; E Klar
Journal:  Anaesthesist       Date:  2007-09       Impact factor: 1.041

3.  Efficacy of topical recombinant human platelet derived growth factor on wound healing in patients with chronic diabetic lower limb ulcers.

Authors:  Shyam S Jaiswal; R P S Gambhir; Amit Agrawal; S Harish
Journal:  Indian J Surg       Date:  2010-02-05       Impact factor: 0.656

4.  The pioneer use of a modified PRGF-Endoret® technique for wound healing in a hemodialyzed diabetic patient in a terminal stage of renal disease.

Authors:  Ioana Adela Raţiu; Cristian Adrian Raţiu; Viorel Miclăuş; Adina Bianca Boşca; Rümeyza Turan Kazancioğlu; Anne Marie Constantin; Gabriel Cristian Bako; Alina Simona Şovrea
Journal:  Rom J Morphol Embryol       Date:  2021 Apr-Jun       Impact factor: 1.033

Review 5.  Growth factors for treating diabetic foot ulcers.

Authors:  Arturo J Martí-Carvajal; Christian Gluud; Susana Nicola; Daniel Simancas-Racines; Ludovic Reveiz; Patricio Oliva; Jorge Cedeño-Taborda
Journal:  Cochrane Database Syst Rev       Date:  2015-10-28

6.  Associated risk factors and management of chronic diabetic foot ulcers exceeding 6 months' duration.

Authors:  Hassan Gubara Musa; Mohamed Elmakki Ahmed
Journal:  Diabet Foot Ankle       Date:  2012-10-30

Review 7.  Becaplermin gel in the treatment of diabetic neuropathic foot ulcers.

Authors:  Nikolaos Papanas; Efstratios Maltezos
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

8.  Cytokine-Rich Adipose Tissue Extract Production from Water-Assisted Lipoaspirate: Methodology for Clinical Use.

Authors:  Jenny Lopez; Outi Huttala; Jertta-Riina Sarkanen; Ilkka Kaartinen; Hannu Kuokkanen; Timo Ylikomi
Journal:  Biores Open Access       Date:  2016-09-01

Review 9.  Platelet Rich Plasma: New Insights for Cutaneous Wound Healing Management.

Authors:  Deborah Chicharro-Alcántara; Mónica Rubio-Zaragoza; Elena Damiá-Giménez; José M Carrillo-Poveda; Belén Cuervo-Serrato; Pau Peláez-Gorrea; Joaquín J Sopena-Juncosa
Journal:  J Funct Biomater       Date:  2018-01-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.